Cargando…

A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services

The National Center for Education Statistics reported that between 1990–2005 the number of children receiving special education services (SES) rose significantly, and then, from 2004–2012, the number declined significantly. This coincided with the introduction of Thimerosal-containing hepatitis B va...

Descripción completa

Detalles Bibliográficos
Autores principales: Geier, David A., Kern, Janet K., Homme, Kristin G., Geier, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800222/
https://www.ncbi.nlm.nih.gov/pubmed/29329213
http://dx.doi.org/10.3390/ijerph15010123
_version_ 1783298169920028672
author Geier, David A.
Kern, Janet K.
Homme, Kristin G.
Geier, Mark R.
author_facet Geier, David A.
Kern, Janet K.
Homme, Kristin G.
Geier, Mark R.
author_sort Geier, David A.
collection PubMed
description The National Center for Education Statistics reported that between 1990–2005 the number of children receiving special education services (SES) rose significantly, and then, from 2004–2012, the number declined significantly. This coincided with the introduction of Thimerosal-containing hepatitis B vaccine in 1991, and the subsequent introduction of Thimerosal-reduced hepatitis B vaccine in the early 2000s. This study examined the potential relationship between infant exposure to mercury from three doses of Thimerosal-containing hepatitis B vaccine and the risk of boys being adversely affected (as measured by receipt of SES). This cross-sectional study examined 1192 boys (weighted n = 24,537,123) 7–8 years of age (born: 1994–2007) from the combined 2001–2014 National Health and Nutritional Examination Survey (NHANES). Survey logistic regression modeling revealed that an exposed population receiving three doses of infant Thimerosal-containing hepatitis B vaccine (weighted n = 11,186,579), in comparison to an unexposed population (weighted n = 704,254), were at an increased risk of receipt of SES. This association was robust (crude odds ratio = 10.143, p = 0.0232), even when considering covariates, such as race and socioeconomic status (adjusted odds ratio = 9.234, p = 0.0259). Survey frequency modeling revealed that receipt of SES for the population that was exposed to three doses of Thimerosal-containing hepatitis B vaccine in infancy (12.91%) was significantly higher than the unexposed population (1.44%) (prevalence ratio = 8.96, p = 0.006, prevalence attributable rate = 0.1147). Despite the limitation of this cross-sectional study not being able to ascribe a direct cause-and-effect relationship between exposure and outcome, it is estimated that an additional 1.2 million boys received SES with excess education costs of about United States (US) $180 billion associated with exposure to Thimerosal-containing hepatitis B vaccine. By contrast, exposure to Thimerosal-reduced hepatitis B vaccine was not associated with an increased risk of receiving SES. Therefore, routine childhood vaccination is important to reduce the morbidity and mortality of infectious diseases, but every effort should be made to eliminate Thimerosal from all vaccines.
format Online
Article
Text
id pubmed-5800222
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58002222018-02-06 A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services Geier, David A. Kern, Janet K. Homme, Kristin G. Geier, Mark R. Int J Environ Res Public Health Article The National Center for Education Statistics reported that between 1990–2005 the number of children receiving special education services (SES) rose significantly, and then, from 2004–2012, the number declined significantly. This coincided with the introduction of Thimerosal-containing hepatitis B vaccine in 1991, and the subsequent introduction of Thimerosal-reduced hepatitis B vaccine in the early 2000s. This study examined the potential relationship between infant exposure to mercury from three doses of Thimerosal-containing hepatitis B vaccine and the risk of boys being adversely affected (as measured by receipt of SES). This cross-sectional study examined 1192 boys (weighted n = 24,537,123) 7–8 years of age (born: 1994–2007) from the combined 2001–2014 National Health and Nutritional Examination Survey (NHANES). Survey logistic regression modeling revealed that an exposed population receiving three doses of infant Thimerosal-containing hepatitis B vaccine (weighted n = 11,186,579), in comparison to an unexposed population (weighted n = 704,254), were at an increased risk of receipt of SES. This association was robust (crude odds ratio = 10.143, p = 0.0232), even when considering covariates, such as race and socioeconomic status (adjusted odds ratio = 9.234, p = 0.0259). Survey frequency modeling revealed that receipt of SES for the population that was exposed to three doses of Thimerosal-containing hepatitis B vaccine in infancy (12.91%) was significantly higher than the unexposed population (1.44%) (prevalence ratio = 8.96, p = 0.006, prevalence attributable rate = 0.1147). Despite the limitation of this cross-sectional study not being able to ascribe a direct cause-and-effect relationship between exposure and outcome, it is estimated that an additional 1.2 million boys received SES with excess education costs of about United States (US) $180 billion associated with exposure to Thimerosal-containing hepatitis B vaccine. By contrast, exposure to Thimerosal-reduced hepatitis B vaccine was not associated with an increased risk of receiving SES. Therefore, routine childhood vaccination is important to reduce the morbidity and mortality of infectious diseases, but every effort should be made to eliminate Thimerosal from all vaccines. MDPI 2018-01-12 2018-01 /pmc/articles/PMC5800222/ /pubmed/29329213 http://dx.doi.org/10.3390/ijerph15010123 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Geier, David A.
Kern, Janet K.
Homme, Kristin G.
Geier, Mark R.
A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services
title A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services
title_full A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services
title_fullStr A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services
title_full_unstemmed A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services
title_short A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services
title_sort cross-sectional study of the association between infant hepatitis b vaccine exposure in boys and the risk of adverse effects as measured by receipt of special education services
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800222/
https://www.ncbi.nlm.nih.gov/pubmed/29329213
http://dx.doi.org/10.3390/ijerph15010123
work_keys_str_mv AT geierdavida acrosssectionalstudyoftheassociationbetweeninfanthepatitisbvaccineexposureinboysandtheriskofadverseeffectsasmeasuredbyreceiptofspecialeducationservices
AT kernjanetk acrosssectionalstudyoftheassociationbetweeninfanthepatitisbvaccineexposureinboysandtheriskofadverseeffectsasmeasuredbyreceiptofspecialeducationservices
AT hommekristing acrosssectionalstudyoftheassociationbetweeninfanthepatitisbvaccineexposureinboysandtheriskofadverseeffectsasmeasuredbyreceiptofspecialeducationservices
AT geiermarkr acrosssectionalstudyoftheassociationbetweeninfanthepatitisbvaccineexposureinboysandtheriskofadverseeffectsasmeasuredbyreceiptofspecialeducationservices
AT geierdavida crosssectionalstudyoftheassociationbetweeninfanthepatitisbvaccineexposureinboysandtheriskofadverseeffectsasmeasuredbyreceiptofspecialeducationservices
AT kernjanetk crosssectionalstudyoftheassociationbetweeninfanthepatitisbvaccineexposureinboysandtheriskofadverseeffectsasmeasuredbyreceiptofspecialeducationservices
AT hommekristing crosssectionalstudyoftheassociationbetweeninfanthepatitisbvaccineexposureinboysandtheriskofadverseeffectsasmeasuredbyreceiptofspecialeducationservices
AT geiermarkr crosssectionalstudyoftheassociationbetweeninfanthepatitisbvaccineexposureinboysandtheriskofadverseeffectsasmeasuredbyreceiptofspecialeducationservices